Top Markets
Coin of the day
Lumos Diagnostics Holdings Limited Lumos Diagnostics Holdings Limited

Lumos Diagnostics Holdings Limited

LDX
Rank in Stocks #23727
Lumos Diagnostics Holdings Limited develops, manufactures, and commercializes... Lumos Diagnostics Holdings Limited develops, manufactures, and commercializes point-of-care diagnostic products for diagnosis and management of infectious diseases in the United States. The company’s products include FebriDx, a point-of-care diagnostic test for detecting and differentiating viral and bacterial respiratory infections; and ViraDx, a three-in-one point-of-care test for influenza A, influenza B, and COVID-19. It also provides assay development and manufacturing services for point-of-care tests and proprietary digital reader platforms. Lumos Diagnostics Holdings Limited was incorporated in 2018 and is based in Carlsbad, California.
Share Price
$0.0740549
Last synced: 2026-08-21
Market Cap
$69.97M
Change (1 day)
0.00%
Change (1 year)
21.33%
Country
AU
Trade Lumos Diagnostics Holdings Limited (LDX)

Category

Number of shares outstanding for Lumos Diagnostics Holdings Limited (LDX)
Number of shares outstanding as of August 2026: 0
According to Lumos Diagnostics Holdings Limited latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of August 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Lumos Diagnostics Holdings Limited (LDX) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors